bioRxiv. 2021 Apr 14:2021.04.13.439709. doi: 10.1101/2021.04.13.439709. Preprint. ABSTRACT Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains
bioRxiv. 2021 Mar 10:2021.03.10.434840. doi: 10.1101/2021.03.10.434840. Preprint. ABSTRACT Memory B cell reserves can generate protective antibodies against repeated SARS-CoV-2 infections, but with an unknown reach
JCI Insight. 2021 Jan 11;6(1):e143129. doi: 10.1172/jci.insight.143129. ABSTRACT The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), coupled with a lack of therapeutics,
Cell. 2020 Dec 10;183(6):1496-1507.e16. doi: 10.1016/j.cell.2020.10.051. Epub 2020 Nov 3. ABSTRACT Antibodies are key immune effectors that confer protection against pathogenic threats. The nature and
Open Forum Infect Dis. 2020 Sep 26;7(10):ofaa447. doi: 10.1093/ofid/ofaa447. eCollection 2020 Oct. ABSTRACT Chronic granulomatous disease (CGD) is a primary immunodeficiency syndrome that results in
Science. 2020 Nov 27;370(6520):eabd4250. doi: 10.1126/science.abd4250. Epub 2020 Sep 29. ABSTRACT Understanding humoral responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for
J Immunol Methods. 2020 Sep-Oct;484-485:112832. doi: 10.1016/j.jim.2020.112832. Epub 2020 Aug 8. ABSTRACT Critical to managing the spread of COVID-19 is the ability to diagnose infection
Science. 2020 Aug 14;369(6505):806-811. doi: 10.1126/science.abc6284. Epub 2020 May 20. ABSTRACT The global coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus
Science. 2020 Mar 6;367(6482):1072-1073. doi: 10.1126/science.aba8974. NO ABSTRACT PMID:32139528 | PMC:PMC8063504 | DOI:10.1126/science.aba8974
Sci Immunol. 2019 Nov 1;4(41):eaaz4195. doi: 10.1126/sciimmunol.aaz4195. ABSTRACT B cell receptor sequencing sheds light on how measles cripples the immune system long after recovery from